TrialPath
Recruiting

Plant-Based Online Weight Loss Through Education and Resources Program and Study

NCT07095543 · Physicians Committee for Responsible Medicine
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
Feasibility, Implementation, and Efficacy of a Plant-based Online Weight Loss Through Education and Resources Program and Study (POWER Study)
About this study
This is an interventional study that will evaluate the feasibility, implementation, and efficacy of an online, 12-week, plant-based, nutrition education program in a community setting. Participants will participate in weekly physician- and dietitian-lead group classes and will receive education about a plant-based diet as well as support and practical tips for implementing the dietary changes. Participants will receive baseline and 12 week assessments including a DXA scan to assess body composition, HbA1c, lipid panel, and a food cost analysis.
Eligibility criteria
Inclusion Criteria: * U.S. men and women meeting the age of majority, defined as follows: Age 19 or older in Nebraska and Alabama. Age 21 or older in Puerto Rico. Age 18 or older in all other states. * Able and willing to travel to Washington DC for a dual-energy х-rау absorptiometry (DXA) scans before and after the program. * Able and willing to complete laboratory assessments at a local LabCorp facility before and after the program. * Able and willing to participate in all components of the study. * BMI of 25 or more (23 or more in persons of Asian origin). * Access to the internet. * English fluency. Exclusion Criteria: * Use of recreational drugs in the past 6 months. * Pregnancy or intention to become pregnant during the study period, as verified by self-report. * Unstable medical or psychiatric illness. * Inability to maintain medication regimen as prescribed by personal healthcare provider. * Current or expected use of any weight loss medication during the study period, including but not limited to, glucagon-like peptide-1 (GLP-1) receptor agonists and combination GLP-1 receptor/glucose-dependent insulinotropic polypeptide (GIP) agonists. * Use of any weight loss medication within the 12 months preceding the study period, including but not limited to, glucagon-like peptide-1 (GLP-1) receptor agonists and combination GLP-1 receptor/glucose-dependent insulinotropic polypeptide (GIP) agonists. * Body weight greater than 182 kg. * Current diagnosis of eating disorder. * Intention to follow another weight loss method during the study period.
Study design
Enrollment target: 100 participants
Allocation: na
Masking: none
Age groups: adult, older_adult
Timeline
Starts: 2026-01-02
Estimated completion: 2028-10-30
Last updated: 2026-09-17
Interventions
Behavioral: Low-fat, vegan diet
Primary outcomes
  • • The feasibility of an online plant-based weight loss program in the community setting. (From baseline to the end of the intervention at 12 weeks.)
Sponsor
Physicians Committee for Responsible Medicine · other
Contacts & investigators
ContactVanita Rahman, MD, DipACLM · contact · vrahman@pcrm.org · 202-527-7500
ContactShannon Menhardt, MS, RD · contact · smenhardt@pcrm.org · 202-527-7500
All locations (1)
Physicians Committee for Responsible MedicineRecruiting
Washington D.C., District of Columbia, United States
Plant-Based Online Weight Loss Through Education and Resources Program and Study · TrialPath